Nucleic Acid Encoding Novel Human Kdel Receptor

Abstract

The present invention provides a novel human KDEL receptor (NHKR) and polynucleotides which identify and encode NHKR. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NHKR and a method for producing NHKR. The invention also provides for agonists, antibodies, or antagonists specifically binding NHKR, and their use, in the prevention and treatment of diseases associated with expression of NHKR. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NHKR for the treatment of diseases associated with the expression of NHKR. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NHKR.


Claims
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Oct 20, 1998
  • Application: Nov 21, 1996
    US US 75315996 A
  • Priority: Nov 21, 1996
    US US 75315996 A

Download Citation


Sign in to the Lens

Feedback